SYSTEM AND METHOD FOR INFUSION SET DISLODGEMENT DETECTION

• US 20140378898A1
• Filed: 06/21/2013
• Published: 12/25/2014
• Est. Priority Date: 06/21/2013
• Status: Active Grant

• Current Assignee: Tandem Diabetes Care Incorporated
• Original Assignee: Tandem Diabetes Care Incorporated
• Inventors: Rosinko, Michael
• Granted Patent: US 9,867,953 B2
• Time in Patent Office: Days
• US Class Current: 604/111
• CPC Class Codes: A61M 2205/13 with means for the detection of operative contact with patient, e.g. lip sensor
• CPC Class Codes: A61M 5/16836 by sensing tissue properties at the infusion site, e.g. for detecting infiltration detecting tissue temperature for diagnostic purposes A61M39/0247
• CPC Class Codes: A61M 5/5086 for indicating if defective, used, tampered with or unsterile

Abstract

A portable insulin pump can utilize readings from a sensor incorporated into an infusion set used with the pump to deliver insulin to a patient to determine if the infusion set is or is likely to become dislodged from the patient. Readings from the sensor that are inconsistent with expected readings or a range of expected readings can indicate that the infusion set has become dislodged from the patient.

Claims

1. A portable insulin pump, comprising:

a user interface adapted to display operating information and to receive input data from a user;

a receiver adapted to receive information obtained by a glucose sensor; and

a processor functionally linked to the receiver to receive the information obtained by the glucose sensor and to the user interface to control display of information on the user interface, wherein the processor is configured to;

determine from the information obtained by the glucose sensor whether or not an infusion set connecting the pump to a patient to deliver insulin is or is likely to become dislodged from the patient; and

provide an alert relating to dislodgement of the infusion set from the patient if it is determined from the information obtained by the glucose sensor that the infusion set is or is likely to become dislodged.

2. The portable insulin pump of claim 1, wherein the processor determines that the infusion set is or is likely to become dislodged if one or more readings obtained by the glucose sensor are outside of an expected range.

3. The portable insulin pump of claim 1, wherein the processor determines that the infusion set is or is likely to become dislodged if it receives a reading from the glucose sensor that is above a high threshold or below a low threshold.

4. The portable insulin pump of claim 1, wherein the processor is further configured to discontinue delivery of insulin upon determining that the infusion set is or is likely to become dislodged.

5. The portable insulin pump of claim 1, wherein the receiver receives the information obtained by the glucose sensor directly from the glucose sensor.

6. The portable insulin pump of claim 1, wherein the receiver receives the information obtained by the glucose sensor from a standalone glucose monitor functionally linked with the glucose sensor.

7. The portable insulin pump of claim 1, further comprising the infusion set, the infusion set including a cannula inserted into the patient, and wherein the glucose sensor and the cannula are adapted to be integrated with each other at a common insertion site.

8. The portable insulin pump of claim 1, further comprising the infusion set, the infusion set including a cannula inserted into the patient, and wherein the glucose sensor and the cannula are adapted to be inserted at different insertion sites on the patient.

9. The portable insulin pump of claim 8, wherein the cannula and the glucose sensor are mechanically linked to each other.

10. The portable insulin pump of claim 9, wherein the cannula and the glucose sensor are mechanically linked to each other by both being connected to a patch adapted to retain the infusion set on the patient.

11. A portable infusion system, comprising:

a portable insulin pump including a user interface adapted to display operating information and to receive input data from a user, a receiver and a processor functionally linked to the receiver to receive information from the receiver and to the user interface to control display of information on the user interface;

a glucose sensor adapted to obtain information relating to glucose levels of a patient that is received by the portable insulin pump through the receiver; and

an infusion set, the infusion set including a cannula adapted to be inserted into the patient, tubing attached to the cannula to transmit insulin delivered with the pump to the cannula and an adhesive patch adapted to retain the infusion set on the patient; and

wherein the processor of the insulin pump is adapted to;

determine from the information obtained by the glucose sensor whether or not the cannula is or is likely to become dislodged from the patient; and

provide an alert on the user interface relating to dislodgement of the cannula from the patient if it is determined from the information obtained by the glucose sensor that the cannula is or is likely to become dislodged.

12. The portable insulin system of claim 11, wherein the processor determines that the cannula is or is likely to become dislodged if one or more readings obtained by the glucose sensor are outside of an expected range.

13. The portable insulin system of claim 11, wherein the processor determines that the cannula is or is likely to become dislodged if it receives a reading from the glucose sensor that is above a high threshold or below a low threshold.

14. The portable insulin system of claim 11, wherein the processor is further configured to discontinue delivery of insulin upon determining that the cannula is or is likely to become dislodged.

15. The portable insulin system of claim 11, wherein the receiver receives the information obtained by the glucose sensor directly from the glucose sensor.

16. The portable insulin system of claim 11, wherein the receiver receives the information obtained by the glucose sensor from a standalone glucose monitor functionally linked with the glucose sensor.

17. The portable insulin system of claim 11, wherein the glucose sensor and the cannula are adapted to be integrated with each other at a common insertion site.

18. The portable insulin system of claim 11, wherein the glucose sensor and the cannula are adapted to be inserted at different insertion sites on the patient.

19. The portable insulin system of claim 18, wherein the cannula and the glucose sensor are mechanically linked to each other.

20. The portable insulin system of claim 19, wherein the cannula and the glucose sensor are mechanically linked to each other by both being connected to the adhesive patch.